Cytokine-induced neutrophil chemoattractant 1 (CINC-1) mediates the sympathetic component of inflammatory mechanical hypersensitivitiy in rats

Eur Cytokine Netw. 2002 Oct-Dec;13(4):456-61.

Abstract

The hyperalgesic effect of cytokine-induced neutrophil chemoattractant 1 (CINC-1/CXCL1) was measured in a model of mechanical hyperalgesia in rats. CINC-1 evoked a dose-dependent mechanical hypersensitivity, which was already significant 2 h after the cytokine injection, peaked 4 h after and decreased thereafter. The local pre-treatment of the rats with the beta-adrenoceptor antagonist, atenolol (25 microg paw-1), but not with the cyclooxygenase inhibitor indomethacin (100 microg paw-1), inhibited (86%) the CINC-1-induced hypersensitivity. Conversely, IL-1beta-evoked hypersensitivity was inhibited (76%) by local pre-treatment of the animals with indomethacin, but not by atenolol. Carrageenin- and TNF-alpha-evoked hypersensitivity were attenuated to about the same extent (50%) by antisera neutralising CINC-1 or IL-1beta. The association of both antisera abolished the hypersensitivity effect of carrageenin and TNF-alpha. In addition, carrageenin, LPS and TNF-alpha were shown to stimulate the production of immunoreactive CINC-1 in the skin of injected paws. These data suggest that CINC-1, released at sites of inflammation, mediates inflammatory hyperalgesia in rats via release of sympathomimetic amines.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Atenolol / pharmacology
  • Carrageenan / toxicity
  • Chemokine CXCL1
  • Chemokines / antagonists & inhibitors
  • Chemokines / pharmacology
  • Chemokines / physiology*
  • Chemokines, CXC*
  • Chemotactic Factors / antagonists & inhibitors
  • Chemotactic Factors / pharmacology
  • Chemotactic Factors / physiology*
  • Hyperalgesia / etiology*
  • Hyperalgesia / physiopathology
  • Indomethacin / pharmacology
  • Inflammation Mediators / antagonists & inhibitors
  • Inflammation Mediators / pharmacology
  • Inflammation Mediators / physiology*
  • Intercellular Signaling Peptides and Proteins / pharmacology
  • Intercellular Signaling Peptides and Proteins / physiology*
  • Interleukin-1 / antagonists & inhibitors
  • Interleukin-1 / physiology
  • Lipopolysaccharides / toxicity
  • Male
  • Nociceptors / drug effects
  • Nociceptors / physiopathology
  • Rats
  • Rats, Wistar
  • Sympathetic Nervous System / drug effects
  • Sympathetic Nervous System / physiopathology
  • Tumor Necrosis Factor-alpha / pharmacology

Substances

  • Chemokine CXCL1
  • Chemokines
  • Chemokines, CXC
  • Chemotactic Factors
  • Cxcl1 protein, rat
  • Inflammation Mediators
  • Intercellular Signaling Peptides and Proteins
  • Interleukin-1
  • Lipopolysaccharides
  • Tumor Necrosis Factor-alpha
  • Atenolol
  • Carrageenan
  • Indomethacin